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REVIEW

Lessons from Sicilian Centenarians for Anti-Ageing
Medicine. The Oxi-Inﬂammatory Status
Calogero Caruso*, Giulia Accardi, Anna Aiello, Anna Calabr
o,
Mattia E. Ligotti, Giuseppina Candore
Laboratory of Immunopathology and Immunosenescence, Department of Biomedicine, Neuroscience and Advanced Diagnostics,
University of Palermo, Palermo, Italy

Abstract
Population ageing is a great achievement of humanity, but it also represents a challenge that the Western world is
currently facing, as ageing is associated with increased susceptibility to age-related inﬂammatory diseases. Therefore, it
is necessary to fully understand the mechanisms of healthy ageing to prevent the harmful aspects of ageing. The study of
long living ndividuals (LLIs) is a great model for trying to achieve this goal. Accordingly, the oxy-inﬂammatory status of
Sicilian LLIs was reviewed in the present paper. Based on the reported data, anti-inﬂammatory and anti-oxidative stress
strategies have been discussed, useful for delaying or avoiding the onset of age-related diseases, thus favouring a
healthy ageing process.
Keywords: Centenarians, Inﬂammation, Longevity, Oxidative stress

1. Introduction

P

eople around the world are living longer. In
addition, the pace of ageing of the world population is also increasing [1]. The increasing mean
lifespan of the population is a big success of humanity, but also poses a challenge that industrialized countries are currently facing because the
increase in lifespan does not coincide with the increase in the duration of health, health-span, i.e., the
period of life free from serious chronic diseases and
disabilities [2]. Therefore, improving the quality of
life of oldest people is becoming a priority due to the
continuous increase in the number of this population who is at risk of frailty. This makes the studies
of the processes involved in healthy ageing and
longevity of great importance. The identiﬁcation of
the factors that predispose to a long and healthy life
is therefore of enormous interest for translational
medicine. This means understanding why some
individuals, namely the centenarians, have escaped
neonatal mortality, infectious diseases in the pre-

antibiotic era, and the fatal outcomes of age-related
diseases, thus living more than 100 years. The
knowledge born from this approach could allow
modulating the ageing rate by providing valuable
information on lifestyle to achieve healthy ageing
[3e5].
In the last twelve years, we have surveyed the
population of some Sicilian small towns and villages, characterized by a high rate of centenarians to
investigate the mechanisms involved in longevity
[6e10]. Considering the key role played by inﬂammation and oxidative stress in mechanisms of agerelated diseases [11], we report data related to the
oxi-inﬂammatory status of a homogeneous population of Sicilian centenarians and nonagenarians
(log-living individuals, LLIs) studied together with
young people, adults, and older adults to have an
adequate and matched number of controls. Data are
summarized and discussed according to the available literature, for their possible implication for
the prevention and/or treatment of age-related
diseases.
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2. Oxi-inﬂammatory status of Sicilian LLIs
Inﬂammation is deﬁned as a localized response
with systemic consequences, elicited by trauma or
infection, which helps to destroy, reduce, or
sequester both the harmful agent and the wounded
tissue, so supporting survival by ﬁghting off pathogenic microbes and healing injuries. Therefore, the
inﬂammation process is not per se a negative phenomenon; it is the response of the innate immune
system to pathogenic viruses or bacteria. However,
older organisms tend to develop a pro-inﬂammatory status characterized by high levels of pro-inﬂammatory markers in cells, tissues, and blood, a
condition called inﬂamm-ageing. In fact, ageing is
accompanied by chronic low grade inﬂammatory
state. This chronic inﬂammation is instrumental in
driving the ageing process in general, and contributes to the development of age-related diseases. In
older people, the tissues have high levels of proinﬂammatory cytokines, which are known to interfere with anabolic signalling, thus contributing to
the development of sarcopenia. During the lifehistory, low-grade inﬂammation, develops gradually and contributes to the pathogenesis of a range
of age-related diseases as cardiovascular diseases
(CDVs), and Type-2 diabetes (T2D), cancer, and
neurodegeneration as well as frailty and sarcopenia
(a far from exhaustive list is shown in Fig. 1).
Therefore, this backdrop of low-grade inﬂammation
contributes signiﬁcantly to mortality risk of older
people and has several sources, as discussed below
[12e15].
Oxidative stress is an oxidative condition, resulting from an imbalance between oxidant and antioxidant factors in favour of the former ones, capable
of damaging DNA, lipids, and proteins with consequent tissue damage and acceleration of ageing
process. With advancing age, the concentrations of
free radical increase because of the age-related
functional decline in the electron transport chain
and changes in the gene expression proﬁle as well
as by the decline of antioxidant systems [16]. The
excess of free radicals interacts with lipids, proteins,
and DNA, altering the normal physiological functions of cells. This ability allows to understand why
oxidative stress is involved in the pathophysiological mechanisms of age-related diseases. In addition, the oxidative stress is thought to be closely
related to inﬂamm-ageing [17]. The increase of free
radicals is correlated to damage-associated molecular pattern (DAMPs) release, endogenous nuclear
or cytosolic molecules released from injured and
dying cells. DAMPs are able to activate inﬂammasome, through speciﬁc receptors, promoting the
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production of pro-inﬂammatory cytokines. In turn,
these cytokines activate inﬂammatory cells, further
potentiating free radicals production, in a vicious
cycle [11].
More in general, cellular injury can release
DAMPs activating innate immunity. So, cell debris
caused by inappropriate cell destruction and clearance during the ageing process can trigger the
innate immune system, which sets the scene for
persistent inﬂammation. Cell debris accumulate
with age because of both increased production and
impaired elimination by defective autophagy
[18,19].
However, the most important causes of inﬂammaageing are represented by cellular senescence and
pathogen burden, both linked to the ageing of immune system, i.e., immunosenescence; in turn,
inﬂamm-ageing contributes to immunosenescence
[20,21].
Cells are driven into a senescent, non-dividing
state by several factors, including telomere shortening, DNA damage, and inﬂammatory cytokines.
These all result in the activation of transcription
factor p53 which is involved in a variety of processes
including DNA repair and apoptosis, but most
notably results in expression of cyclin-dependent
kinase inhibitor p21, which together with activation
of p16, is the major pathways in the induction of
senescence. The immune system clears away these
damaged cells; however, in older people immunosenescence is responsible for a less efﬁciency of the
clearing of these cells declines, hence increasing
numbers linger in tissues and secrete an inﬂammatory cocktail of cytokines known as the senescence-associated secretory phenotype (SASP)
[21,22].
It has been suggested that the reduction in lifetime exposure to infectious diseases and other
sources of inﬂammation contributes to the historical
decline in old-age mortality, strengthening the
suggestion that long-life pathogen burden is a very
important factor for age-related inﬂammation.
Persistent antigenic challenges lead to a poor
response to newly encountered microbial antigens,
as well as to a shift in the immune system toward an
inﬂammatory T helper proﬁle. Late-stage memory
effector T-cells contribute to the pro-inﬂammatory
state in older people as producers of pro-inﬂammatory cytokines. In addition, the long-term chronic
microbial burden induces progressive activation of
macrophages, hence contributing to the chronic
state of low-grade inﬂammation. Accordingly, some
studies have linked an individual exposure to past
infection to levels of chronic inﬂammation and to
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Fig. 1. Cardiovascular diseases, chronic kidney disease, cancer, depression, anaemia, sarcopenia, osteoporosis, and dementia are shown in the ﬁgure
as example of inﬂammatory age-related diseases, since inﬂamm-ageing contributes to the development of these diseases in older people. Moreover,
elevated blood levels of pro-inﬂammatory markers are a powerful risk facor for multimorbidity that, with inﬂamm-ageing, is a strong risk factor for
physical and cognitive disability, frailty, and premature mortality. References in the text.

increased risk of heart attack, stroke, and cancer
[14,15,20,23].
On the other hand, bacteria have developed an
intimate relationship with animals, colonizing speciﬁc body sites at the interface with the body exterior and invaginations, hence constituting an
integrated meta-organism with functional integration conferring signiﬁcant advantages to animals
and bacteria. The immune system of the host coevolved with the microbiota to develop complex
mechanisms to recognize and destroy invading microbes, while preserving its own bacteria. However,
the oral and gut mucosa barriers that protect against
bacterial invasion begin to both decline in effectiveness and break down as human beings age.
Periodontal disease has been shown to shown to
contribute to inﬂamm-ageing by generating chronic,
low-grade inﬂammation. In the gut, the microbiome
shows an increasing decline of diversity with age.
Composition and diversity of the microbiota change
according to development and ageing and
contribute to health and ﬁtness by modulating the
immune system response and inﬂamm-ageing and
vice versa [14,24e26]. Bian et al. [27], collected and
examined the gut microbiota of a cross-sectional
cohort of more than 1000 very healthy Chinese individuals who spanned ages from 3 to over 100
years, showing that the healthiest aged people had

gut microbiomes like much younger people; in
other words, they maintained diversity and thus
lower levels of inﬂammation.
Closely related to inﬂamm-ageing is metaﬂammation, the low-grade, chronic inﬂammation
orchestrated by metabolic cells in response to excess
nutrients and energy. An excess of macronutrients
introduced with the diet determines an increased
circulation of fatty acids and obesity. That leads to
the stimulation of macrophages and the same adipocytes, triggering signal transduction pathways
involved in the pro-inﬂammatory status. In fact, in
subjects affected by visceral obesity increased levels
of pro-inﬂammatory cytokines and decreased adiponectin levels are observed. That triggers an
increased production of free radicals [28]. Thus, proinﬂammatory activation of macrophages in metabolic tissues is critically important in the induction
of obesity-induced metaﬂammation and it has been
demonstrated that the soluble mannose receptor
plays a direct functional role in both macrophage
activation and metaﬂammation [29]. In turn, the
pro-inﬂammatory status induced by metaﬂammation as well as inﬂamm-ageing leads to
cellular damage and senescence, so worsening
inﬂamm-ageing [28].
In a recent multi-cohort study [30], then, using
data from several European countries, it was
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observed that a disadvantageous socioeconomic
status at any stage of life was associated with an
increase in inﬂammation assessed using serum
levels of C-reactive protein (CRP), an acute phase
reactant that responds rapidly to tissue injury,
infection, and inﬂammation. In general, known
behavioural factors (alcohol consumption, smoking
habit, and sedentary lifestyle) and body mass index
(BMI) explained in part, but not completely, the
relationship between socioeconomic status and
inﬂammation. A subsequent analysis indicated that
low-educated participants had higher CRP levels
regardless of socioeconomic status in early life or
adulthood, as well as behavioural factors and BMI.
The persistence of a signiﬁcant association between
low level of education and a high level of CRP in
adulthood indicate that the level of education may
be an upstream risk factor for high inﬂammation.
These ﬁndings suggest that there are other pathways through which socioeconomic status can inﬂuence inﬂammation. These include beyond
education, for example, exposure to xenobiotics and
pollutants, junk food and infectious diseases, as well
as psychosocial stress [31].
About food, an important turning point in the
study of the relationship between diet, healthy
ageing, and inﬂammation was the deﬁnition of the
Diet Inﬂammatory Index (DII) which allows to
quantify the pro or anti-inﬂammatory power of a
speciﬁc food. Following the introduction of DII, it is
possible to identify dietary regimens associated with
an increased risk of metabolic disorders, CVDs, and
cancer, and mutually healthy ageing and longevity
[28].
As previously stated, oxidative stress plays an
important role also in determining and maintaining
the typical low-grade inﬂammation, in turn
contributing to oxidative stress. Concerning Sicilian
centenarians [7,32], the main product of the polyunsaturated fatty acids peroxidation, malondialdehyde, is not signiﬁcantly different between
centenarians and controls of younger age. On the
other hand, the range values of blood glutathione in
these centenarians have been shown to be included
in the value range of young people. Paraoxonase
(PON) is an enzyme associated with high density
lipoproteins, believed to protect against the oxidation (ox-) of low-density lipoproteins (LDL), so
protecting from the risk of coronary artery disease.
In Sicilian centenarians, PON units are not signiﬁcantly different from those observed in young people. Interestingly, the value range of ox-LDL in these
centenarians has been shown to be lower than that
observed in young people It is seemingly puzzling
that the total antioxidant capacity is lower in young
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people than in the other groups and that the highest
values are observed in nonagenarians. It can be
hypothesized that the eating habits of adults and
older people, more adherent to MedDiet than young
people (see above) could contribute to our observations [7,32]. Our results agree with most literature
reporting decrease of oxidative stress in LLIs. In
most studies, indeed, centenarians showed lower
levels of lipid peroxides, and higher plasma levels of
antioxidant vitamin E than older controls, suggesting that they may be better equipped to contrast
oxidative stress [11].
Concerning inﬂammatory markers of Sicilian LLIs
[7], we observed a not signiﬁcant increase of
neutrophil/lymphocyte (N/L) ratio that is an
emerging inﬂammatory marker because it combines
the predictive power of both decreased lymphocyte
and increased neutrophil counts. In people aged 55
years and older, this ratio has been described to be
associated with mortality [33]. Albumin and total
proteins levels are decreased in LLIs in agreement
with results obtained in several centenarian studies.
Albumin has been used as a biochemical indicator
of nutritional status, but decreased albumin levels
are also a reﬂection of inﬂammatory status, as
negative acute phase protein [34]. Signiﬁcantly
higher concentrations of CRP have been observed in
Sicilian LLIs as compared to their controls, although
the increase was not signiﬁcant in centenarians, in
the present study, as well as in several other reports
[34]. The signiﬁcant iron serum level decrease
observed in Sicilian LLIs is not surprising because
levels of circulating hepcidin, elevated in response
to inﬂammation, are responsible for changes in iron
metabolism that results in systemic iron depletion,
although another contributory factor might be the
scarcity of iron content in the diet [35]. In addition,
Sicilian LLIs have been shown to present the
kynurenine/tryptophan (Kyn/Trp) ratio higher than
in all other age-groups [7]. The Kyn/Trp ratio has
been suggested to represent a valuable marker for
the rate of inﬂamm-ageing [36].
Is inﬂamm-ageing compatible with longevity, i.e.,
100 years of age or more? As just demonstrated, the
answer is positive and apparently paradoxical,
since, even if centenarians may have an increased
level of inﬂammatory mediators in comparison to
older subjects and they are very frail, they should
have high level of anti-inﬂammatory molecules
together with protective genotypes.
Accordingly, LLIs belonging to this cohort displayed an increased enzymatic activity of the
extracellular proteinase matrix metalloproteinase 2
known to regulate intercellular communication,
including inﬂammation [37].
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More interestingly are the data concerning the
proﬁles of circulating microRNAs (miRNA) that
appear to be related to chronological age [38]. Variations in plasmatic levels of mir-146a-5p, mir126e3p, and mir-21e5p, three miRNAs involved in
pathways related to inﬂammation, senescence, and
carcinogenesis, seem to be characteristic of the
longevity phenotype. Another ageing-associated
microRNA is mir-181a. This miRNA is involved in
the control of innate immunity and inﬂammation
and its low levels are correlated to higher risk of
coronary artery disease. These suggestions have
been strengthened by two our previous studies.
Recently [32], we have reported a case of a female
supercentenarian in seemingly good health despite
some laboratory signs of atrophic gastritis and a
chronic status of inﬂammation. Her high level of
plasmatic miR-181a suggested that the anti-inﬂammatory effects of this miRNA has conferred, to this
subject protection against tissue damage. Previously
we reported the exceptional case of two sisters, semi
and supercentenarian [39], showing plasmatic levels
of mir-146a-5p, mir-126e3p, and mir-21e5p comparable to those measured in young (24e39 years)
and middle-aged individuals (50e64 years), rather
than those found in older subjects (66e84 years). It
is intriguing that all the three miRNAs are induced
by endothelial dysfunctions and that supercentenarians have been claimed to markedly delay
and even escape clinical expression of vascular
disease toward the end of their exceptionally long
lives. Moreover, the three microRNA plasmatic
levels observed in sisters suggest that the two subjects were experiencing healthy ageing conditions
relatively to age-related diseases. These observations on the control of inﬂammation and age-related
disease development have been conﬁrmed by the
results of a recent paper we have performed in a
cohort of Sicilians donors from young to supercentenarians. The circulating levels of four circulating miRNAs including miR-146a-5p, miR-126e3p,
miR-21e5p, and miR-181a-5p, involved in several
pathways related to inﬂammation, and endothelial
cell senescence (ECs) were determined in 78 healthy
Sicilians aged between 22 and 111 years. Contextually, extracellular miRna levels were measured in
human ECs in vitro model, undergoing senescence.
We found that the levels of the four miRNAs, using
ex vivo and in vitro models, progressively increase
with age, apart from ultra-centenarians that showed
levels comparable to those measured in young individuals. Our results [40] contribute to the development of knowledge regarding the identiﬁcation of
miRNAs as biomarkers of successful and unsuccessful ageing. Indeed, they might have diagnostic/

prognostic relevance for age-related diseases. That,
then, suggests the potentiality of miRNA levels
restoration or the use of their mimics as therapeutic
agents for age-related inﬂammatory diseases.
Also, anti-inﬂammatory genotypes may play a
role [12]. In fact, male Sicilian centenarians,
recruited in a precedent survey with Southern Italy
centenarians, showed a higher frequency of the
anti-inﬂammatory alleles of CC chemokine receptor
5, 5-lipoxygenase, cyclo-oxygenase 2, Toll-like-receptor-4 and cytokine genes, so favouring the control of inﬂamm-ageing and the onset of age-related
diseases [41,42].
As previously described, age-related diseases are
characterized by common background in which
inﬂamm-ageing and oxidative stress play the major
causative role. Therefore, the preventive measures
should be early and complex, resulting in the
lowering of pro-inﬂammatory state in the older, and
so in complex protection from the age-related diseases [43e45].
This goal can be achieved by: i) Early poly-vaccination against pathogens known to recur or reinfect
leading to inﬂammatory response; if a chronic
infection is already present (cytomegalovirus as an
example), it should be treated with the use of antiviral drugs, antibiotics, anti-mycotic to decrease the
pathogen load and the amount of inﬂammatory
response [44,46]; ii) Reasonable and personalized
use of anti-inﬂammatory treatment even in healthy
older exhibiting elevated levels of proinﬂammatory
cytokines with statins and non-steroidal anti-inﬂammatory drugs [47]; iii) Preventing and curing
microbiome dysbiosis with the use of pre- and
probiotics since optimal gut microbiota plays a role
as anti-inﬂammatory agent [48], iv) Preventing
accumulation of senescent cells and disrupting
these already present with the use of senolytics
drugs as reported below.
Stimulation of cell death by using pharmacologically active small molecules, senolytic drugs, should
represent a promising anti-inﬂammatory treatment
and a more general anti-ageing treatment since senescent cells contribute to tissue dysfunction [49].
As discussed by Paez-Ribes et al. [50], different
strategies can be potentially implemented. The use
of apoptosis-inducing drugs that inhibit of prosurvival pathways represents the leading approach.
In fact, inhibitors of the BCL-2 cell death regulator
family of proteins can induce selective apoptosis of
senescent cells. The dampening of the expression of
SASP factors by molecules that interfere with transcriptional factors involved in the secretion of proinﬂammatory mediators has also proven beneﬁcial
in some settings. Then, genetic, and epigenetic
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manipulation of cells, including the induction of
reprogramming, have been proposed as a means of
bypassing or reverting the state of cellular senescence. Finally, the activation of the immune system
against senescent cells to stimulate their clearance
by enhancing the cytotoxic activity of NK against
senescent cells, and manipulating the humoral
innate immunity with the use of antibodies against
receptors, represents another possibility. At this
regard, recently it was reported that chimeric antigen receptor (CAR) T cells can be redirected to
target senescent cells in animal models. CAR T cells
that speciﬁcally target senescent cells could be a
novel senolytic treatment strategy for senescenceassociated diseases. In mice, senescence-targeted
CAR T cells extended survival in lung cancer and
improved liver ﬁbrosis [51].
However, as Sicilian centenarians show, the most
efﬁcient interventions would seem to be the multimodal lifelong lifestyle interventions. As discussed
by Accardi et al. [6], that includes: i) The anti-inﬂammatory Mediterranean Diet characterized by
abundance of fruit and vegetables rich in phytochemicals with anti-oxidant properties [52], and a
limited intake of meat and of reﬁned sugars; ii)
physical exercise since exercise-deprivation induces
a cluster of physiological abnormalities, like metabolic syndrome (such as insulin resistance, impaired
glucose uptake and hyperlipidaemia); iii) satisfactory social interactions with a healthy psychological
approach to mitigate life stress.

3. Conclusions
Population ageing has great social and economic
consequences. As previously stated, ageing of population is a great achievement of humanity, but it
also represents a challenge that Western world is
currently facing, as ageing is associated with
increased susceptibility to many diseases such as
CVDs, cancer, T2D, Alzheimer and Parkinson diseases. Therefore, it is necessary to fully understand
the mechanisms of successful ageing to prevent the
harmful aspects of ageing. As discussed in this review, the study of centenarians is a ﬁne model for
trying to achieve this. On this basis, anti-ageing
strategies aimed not to rejuvenate but to slow
ageing and to delay or avoid the onset of age-related
diseases have been discussed, hence people will be
able to substantially slow down the ageing process,
extending productive, youthful lives.
Successful ageing is inherently a highly plastic trait
that responds to extensive lifestyle changes: exercise,
eating habits, living conditions, and nutritional interventions as demonstrated by the following study.
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Analysed data on morbidity and mortality patterns of
CVDs among 34 million Americans from 1999 to 2000
demonstrated that hospitalizations due to heart
attack and stroke have reduced to 38% and 34%,
respectively. The Authors attributed this dramatic
success to lifestyle changes, besides better treatment,
and preventive measures. Thus, both recommended
and self-motivated lifestyle changes to reduce cardiovascular disease risks, must have also contributed
to the overall health and longevity of at least a fraction of the U.S. population [53,54].
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